Precision medicine aims to define and treat Parkinson’s by tailoring the right therapy to each person, depending not only on their specific signs and symptoms, but also on the specific molecular signatures of their disease.
Wide range of evidence supporting potential interactions
TMEM230 gene association with familial cases of Parkinson’s.
Scientists uncovered how LRRK2 gene regulates cellular transport.
Pesticides inhibiting ALDH enzyme and increased Parkinson’s disease risk.